NICE has developed a medtech innovation briefing (MIB) on Tegaderm CHG securement dressing for vascular access sites.

NICE has published guidance on using Tegaderm CHG IV securement dressings in critically ill adults who need a central venous or arterial catheter in intensive care or high dependency units.

There are no plans to develop guidance on using Tegaderm CHG IV securement dressings in the populations covered by this briefing.

What are MIBs?